Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.

Yanjun ZhongLishu ZhaoGuobao WuChunhong HuChenfang WuMin XuHaiyun DongQuan ZhangGuyi WangBo YuJianlei LvChao WuSiye ZhangChenghui CaoLong ShuYue PanXianling LiuFang Wu

Published in: The Journal of international medical research (2020)

There was no significant association of ACEI/ARB use with mortality in severe COVID-19 patients with hypertension. These findings support the continuation of ACEI/ARB therapy for such patients.

Keyphrases

sars cov
blood pressure
end stage renal disease
coronavirus disease
ejection fraction
cardiovascular events
newly diagnosed
chronic kidney disease
early onset
risk factors
peritoneal dialysis
type diabetes
respiratory syndrome coronavirus